Stock listing

BX Swiss:6IO Inogen, Inc Aktie

Swiss listing (BX Swiss) of Inogen, Inc · home listing NASDAQ:INGN

Follow Inogen, Inc into a list and get an email when it puts out news.

Home listing price · NASDAQ:INGN

$5.30 USD -0.27 (-4.8%)

Close on Nov 20, 2026 · This listing has no price on 6ix; the price shown is the home listing's, NASDAQ:INGN

Past year -19.6% · daily closes, Nov 20, 2025 – Nov 20, 2026, adjusted for splits
Day range
$5.24 – $5.68 USDNov 20, 2026
Volume
351,928 sharesNov 20, 2026
Market cap
$140.7M USDAt the close on Nov 20, 2026 · price × 26.54M shares outstanding
52-week range
$5.05 – $7.67 USDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
$1.82M USDMedian day 257,599 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026
Inogen, Inc logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
NASDAQ:INGN · Home$5.30 USD-0.27 (-4.8%)351,928$5.40$5.675$5.24$5.57Close on Nov 20, 2026
Frankfurt:6IO€4.86 EUR-0.19 (-3.8%)—€4.86€4.86€4.86€5.05Close on Nov 20, 2026

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · NASDAQ:INGN · USD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$5.30-0.27-4.8%$5.40$5.675$5.24351,928
$5.57-0.115-2.0%$5.63$5.76$5.52190,700
$5.685+0.055+1.0%$5.58$5.73$5.52172,747
$5.63-0.06-1.1%$5.67$5.68$5.51238,532
$5.69+0.07+1.2%$5.60$5.71$5.55238,116
$5.62-0.13-2.3%$5.73$5.905$5.61195,038
$5.75-0.25-4.2%$6.00$6.01$5.685286,145
$6.00-0.115-1.9%$6.07$6.07$5.765251,428
$6.115+0.085+1.4%$5.99$6.21$5.865391,619
$6.03-0.74-10.9%$5.08$6.352$5.05974,905
$6.77-0.45-6.2%$7.28$7.33$6.67284,973
$7.22+0.20+2.8%$7.13$7.44$7.13289,497
$7.02+0.15+2.2%$6.90$7.04$6.737201,830
$6.87+0.01+0.1%$6.94$7.205$6.86339,493
$6.86-0.40-5.5%$7.30$7.30$6.69201,105
$7.26+0.01+0.1%$7.34$7.365$7.24257,599
$7.25+0.12+1.7%$7.20$7.30$7.15281,186
$7.13+0.05+0.7%$7.08$7.21$7.05199,609
$7.08-0.02-0.3%$7.00$7.09$6.973191,783
$7.10+0.06+0.9%$7.02$7.16$6.98239,248
$7.04+0.37+5.5%$6.67$7.15$6.67514,176
$6.67-0.02-0.3%$6.65$6.79$6.56185,906
$6.69+0.14+2.1%$6.55$6.71$6.495229,027
$6.55+0.30+4.8%$6.25$6.59$6.25235,192
$6.25-0.045-0.7%$6.30$6.38$6.225193,900
$6.295+0.165+2.7%$6.28$6.373$6.20161,100
$6.13-0.21-3.3%$6.26$6.32$6.05348,900
$6.34-0.08-1.2%$6.44$6.505$6.32293,100
$6.42+0.24+3.9%$6.17$6.45$6.16236,900
$6.18+0.24+4.0%$5.93$6.28$5.93243,900
$5.94+0.12+2.1%$5.79$5.94$5.74454,400
$5.82+0.05+0.9%$5.71$5.88$5.71218,300
$5.77-0.17-2.9%$5.94$5.98$5.765352,900
$5.94-0.03-0.5%$5.95$6.12$5.84349,000
$5.97-0.01-0.2%$6.05$6.05$5.82426,800
$5.98+0.71+13.5%$5.54$6.155$5.541,105,000
$5.27-0.10-1.9%$5.39$5.39$5.265263,400
$5.37-0.07-1.3%$5.44$5.45$5.32232,000
$5.44+0.08+1.5%$5.36$5.50$5.33301,900
$5.36+0.13+2.5%$5.25$5.395$5.20615,400
$5.23+0.14+2.8%$5.10$5.29$5.05433,600
$5.09-0.14-2.7%$5.22$5.29$5.045530,300
$5.23+0.13+2.5%$5.14$5.295$5.105437,900
$5.10-0.04-0.8%$5.18$5.18$5.075350,200
$5.14+0.01+0.2%$5.10$5.18$5.09439,000
$5.130.000.0%$5.17$5.205$5.055442,700
$5.13-0.07-1.3%$5.19$5.27$5.095442,100
$5.20-0.03-0.6%$5.23$5.26$5.16390,700
$5.23-0.08-1.5%$5.30$5.42$5.23311,000
$5.31+0.13+2.5%$5.22$5.35$5.185249,000
$5.18-0.09-1.7%$5.23$5.258$5.155243,400
$5.27+0.04+0.8%$5.19$5.30$5.18203,800
$5.23-0.19-3.5%$5.48$5.54$5.20316,500
$5.42-0.03-0.6%$5.40$5.47$5.37216,600
$5.45+0.06+1.1%$5.41$5.50$5.293272,900
$5.39+0.06+1.1%$5.34$5.47$5.34249,500
$5.33-0.04-0.7%$5.35$5.45$5.32247,000
$5.37-0.13-2.4%$5.46$5.49$5.33306,600
$5.50-0.01-0.2%$5.53$5.66$5.46200,200
$5.51-0.05-0.9%$5.50$5.60$5.50197,400
$5.56+0.02+0.4%$5.51$5.585$5.453230,900
$5.54+0.04+0.7%$5.51$5.59$5.48166,314
$5.50-0.11-2.0%$5.62$5.66$5.50333,491
$5.61+0.01+0.2%$5.64$5.66$5.605140,400
$5.60-0.08-1.4%$5.65$5.706$5.59207,300
Ticker
BX Swiss:6IO
Asset type
Stock
Sector
Health care
Industry
Medical devices & supplies
Exchange
BX Swiss
Currency
CHF

What changed lately

Latest news

All Inogen, Inc news

Inogen, Inc on 6ix

Sector
Health care
Industry
Medical devices & supplies
News releases
18 in the last 12 months · 125 in all · newest Nov 5, 2026 · oldest 2019
Calls
22 calls with a replay · 22 with a transcript · latest Nov 5, 2026
Decks
26 decks · latest Nov 5, 2026

Where Inogen, Inc is listed

ListingExchangeCountryCurrency
NASDAQ:INGN · Home listingNASDAQUnited StatesUSD
LS Exchange:A1XB32LS ExchangeGermanyEUR
Lang & Schwarz:A1XB32Lang & SchwarzGermanyEUR
gettex:6IOgettexGermanyEUR
BOATS:INGNBOATSUnited StatesUSD
BX Swiss:6IO · This pageBX SwissSwitzerlandCHF
Dusseldorf:6IODusseldorfGermanyEUR
Frankfurt:6IOFrankfurtGermanyEUR
Stuttgart:6IOStuttgartGermanyEUR
Tradegate:6IOTradegateGermanyEUR

Valuation

EV/sales 0.2× against a median of 3.4×: 3rd lowest of 11 Medical devices & supplies companies shown. Statements: 4 quarters to Sep 30, 2026 · price Nov 20, 2026

Enterprise value
$58.75M USD
P/E
Loss
EV/sales
0.2×
EV/EBITDA
Negative EBITDA
Price/book
0.9×
Gross margin
44.1%
Operating margin
−11.6%
Net margin
−10.1%
Debt to equity
0.1×
Beta vs S&P 500
0.64

Medical devices & supplies: the 10 companies nearest in size, of 448 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
Inogen, Inc · NASDAQ:INGNUS$140.7MUS$58.75Mn/a0.2×n/a0.9×−10.1%0.1×0.64
PW Medtech Group Ltd. · HKEX:1358US$156.6M−US$114.6M11.1×−0.9×−2.9×0.3×11.5%0.0×n/a
CUREXO Inc. · KRX:060280US$152.5MUS$133.1M37.2×2.3×29.7×2.0×7.1%0.0×n/a
Delta Asia International Corporation · TPEX:6762US$151.3MUS$152.0M213×7.2×18.2×3.8×3.4%0.2×n/a
KORU Medical Systems, Inc. · NASDAQ:KRMDUS$147.3MUS$3.17Tn/a68,440×15,926,569×7.6×−1.8%163,275×1.06
Nextbiomedical Co. Ltd. · KRX:389650US$146.4MUS$120.9M847×9.1×n/a4.0×1.3%0.0×n/a
Paxman AB · OMXSTO:PAXUS$146.2MUS$137.1Mn/a3.8×36.9×3.6×−1.4%0.0×n/a
TriSalus Life Sciences, Inc. · NASDAQ:TLSIUS$143.1MUS$134.5Mn/a2.9×n/a211×−56.6%47.6×1.22
Asterasys Co., Ltd. · KRX:450950US$138.3MUS$124.7M30.6×4.2×26.8×4.1×15.4%0.0×n/a
Hans Biomed Corp · KRX:042520US$135.1MUS$125.0Mn/a1.4×n/a2.3×−15.8%0.1×n/a
MicroTech Medical (Hangzhou) Co., Ltd. Class H · HKEX:2235US$127.9M−US$86.42M21.2×−0.9×−10.0×0.4×6.1%0.1×n/a
Median of the othersUS$146.3MUS$129.0M33.9×3.4×26.8×3.7×2.4%0.0×1.14

Forecasts

1 strong buy · 1 buy · Analysts' consensus from EODHD, read Nov 20, 2026. Not 6ix's view and not investment advice.

Price target
10.75 USD · Analysts' mean
EPS, year to Dec 2026
-0.29 · 1 analyst
Revenue, year to Dec 2026
311.3M · 2 analysts

Team and board

Officers

OfficerRole
Kevin R.M. SmithGeneral Counsel and Executive Vice President, Business Development
Jason RichardsonChief Financial Officer
Andy RedingChief Operating Officer
Jennifer Yi BoyerExecutive Vice President, Enterprise Enablement and Chief Human Resources Officer
Paul AndreassiExecutive Vice President, Chief Quality and Regulatory Affairs Officer
Philip CorrinSenior Vice President, Operations and Supply Chain
Dominic HultonChief Marketing Officer
Krishna JhaveriChief Medical Officer
Naga RameswamyChief Technology Officer

Board

DirectorRole
Elizabeth MoraChairperson of the Board
Glenn BoehnleinDirector
Heather D. RiderDirector
Kevin KingDirector
Kevin R.M. SmithGeneral Counsel and Executive Vice President, Business Development
Mary Katherine LadoneDirector
Mira SahneyDirector
Vafa JamaliDirector

Events

Calls

CallWhenStatus
Inogen (NASDAQ:INGN) Q3 2026 Earnings CallThu, Nov 05, 2026 · 5:00 PM ETReplay
Inogen (NASDAQ:INGN) Q2 2026 Earnings CallThu, Aug 06, 2026 · 5:00 PM ETReplay
Inogen (NASDAQ:INGN) Q1 2026 Earnings CallThu, May 07, 2026 · 5:00 PM ETReplay
Inogen (NASDAQ:INGN) Q4 2025 Earnings CallTue, Feb 24, 2026 · 5:00 PM ETReplay
Inogen (NASDAQ:INGN) Q3 2025 Earnings CallWed, Nov 05, 2025 · 8:30 AM ETReplay
Inogen (NASDAQ:INGN) Q2 2025 Earnings CallThu, Aug 07, 2025 · 5:00 PM ETReplay
Inogen (NASDAQ:INGN) Q1 2025 Earnings CallWed, May 07, 2025 · 5:00 PM ETReplay
Inogen (NASDAQ:INGN) Q4 2024 Earnings CallTue, Feb 25, 2025 · 5:00 PM ETReplay
Inogen (NASDAQ:INGN) Q3 2024 Earnings CallThu, Nov 07, 2024 · 5:00 PM ETReplay
Inogen (NASDAQ:INGN) Q2 2024 Earnings CallTue, Aug 06, 2024 · 5:00 PM ETReplay
All 22 calls
CallWhenStatus
Inogen (NASDAQ:INGN) Q1 2024 Earnings CallTue, May 07, 2024 · 5:00 PM ETReplay
Inogen (NASDAQ:INGN) Q4 2023 Earnings CallTue, Feb 27, 2024 · 5:00 PM ETReplay
Inogen (NASDAQ:INGN) Q3 2023 Earnings CallTue, Nov 07, 2023 · 5:00 PM ETReplay
Inogen (NASDAQ:INGN) Q2 2023 Earnings CallMon, Aug 07, 2023 · 4:30 PM ETReplay
Inogen (NASDAQ:INGN) Q1 2023 Earnings CallThu, May 04, 2023 · 5:00 PM ETReplay
Inogen (NASDAQ:INGN) Q4 2022 Earnings CallThu, Feb 23, 2023 · 5:00 PM ETReplay
Inogen (NASDAQ:INGN) Q3 2022 Earnings CallWed, Nov 02, 2022 · 8:30 AM ETReplay
Inogen (NASDAQ:INGN) Q2 2022 Earnings CallThu, Aug 04, 2022Replay
Inogen (NASDAQ:INGN) Q1 2022 Earnings CallThu, May 05, 2022 · 7:00 PM ETReplay
Inogen (NASDAQ:INGN) Q4 2021 Earnings CallThu, Feb 24, 2022 · 5:00 PM ETReplay
Inogen (NASDAQ:INGN) Q3 2021 Earnings CallThu, Nov 04, 2021 · 7:00 PM ETReplay
Inogen (NASDAQ:INGN) Q2 2021 Earnings CallWed, Aug 04, 2021 · 4:30 PM ETReplay

Results days

QuarterResultsShare move
Q3 2026Nov 5, 2026 · After close−10.9%
Q2 2026Aug 6, 2026 · After close−6.8%
Q1 2026May 7, 2026 · After close−2.4%
Q4 2025Mar 3, 2026+2.1%
Q3 2025Nov 5, 2025 · Before open−8.3%
Q2 2025Aug 7, 2025 · After close+10.4%
Q1 2025May 7, 2025 · After close−11.4%
Q4 2024Feb 25, 2025 · Before open−3.3%
Q3 2024Nov 7, 2024 · After close+17.2%
Q2 2024Aug 6, 2024 · After close+36.0%
All 20 quarters
QuarterResultsShare move
Q1 2024May 7, 2024 · After close+12.9%
Q4 2023Feb 27, 2024 · After close−32.7%
Q3 2023Nov 7, 2023 · After close−1.1%
Q2 2023Aug 7, 2023 · After close−13.6%
Q1 2023May 4, 2023 · After close−5.4%
Q4 2022Feb 23, 2023 · After close−31.4%
Q3 2022Nov 2, 2022 · Before open−7.8%
Q2 2022Aug 4, 2022 · After close−3.3%
Q1 2022May 5, 2022 · After close+3.5%
Q4 2021Feb 24, 2022 · After close+5.6%

Open Events

Decks

DeckKindSlidesDate
Investor Presentation (November 2026)Investor deck18 slidesNov 5, 2026
Investor Presentation (August 2026)Investor deck19 slidesAug 6, 2026
Q2 2026 Earnings PresentationEarnings9 slidesAug 6, 2026
Q1 2026 Earnings PresentationEarnings8 slidesMay 7, 2026
Q4 2025 Earnings PresentationEarnings10 slidesFeb 24, 2026
Q3 2025 Earnings PresentationEarnings8 slidesNov 5, 2025
Q2 2025 Earnings PresentationEarnings22 slidesAug 7, 2025
Q1 2025 Earnings PresentationEarnings8 slidesMay 7, 2025
Q4 2024 Earnings PresentationEarnings9 slidesFeb 25, 2025
Q3 2024 Earnings PresentationEarnings8 slidesNov 7, 2024
All 26 decks
DeckKindSlidesDate
Q2 2024 Earnings PresentationEarnings8 slidesAug 6, 2024
Q1 2024 Earnings PresentationEarnings8 slidesMay 7, 2024
Q4 2023 Earnings PresentationEarnings9 slidesFeb 27, 2024
Q3 2023 Earnings PresentationEarnings20 slidesNov 7, 2023
Q2 2023 Earnings PresentationEarnings20 slidesAug 7, 2023
Shareholder Meeting (May 2023)Shareholder meeting12 slidesMay 11, 2023
Q1 2023 Earnings PresentationEarnings9 slidesMay 4, 2023
40th Annual J.P. Morgan HealthCare Conference (January 2022)Conference20 slidesJan 10, 2022
Investor Presentation (January 2021)Investor deck21 slidesJan 11, 2021
Investor Presentation (January 2020)Investor deck23 slidesJan 13, 2020
Investor Presentation (September 2019)Investor deck27 slidesSep 9, 2019
Investor Presentation (January 2019)Investor deck27 slidesJan 7, 2019
Investor Presentation (January 2018)Investor deck23 slidesJan 8, 2018
Investor Presentation (January 2017)Investor deck21 slidesJan 9, 2017
Investor Presentation (January 2016)Investor deck25 slidesJan 11, 2016
Investor Presentation (November 2015)Investor deck25 slidesNov 30, 2015

Open Decks

Financings

RaiseDate
Strategic investment of common equity
Announced: about US$27.2M
Buyers: Yuwell (approximately $27.2 million, representing a 9.9% common equity interest, through its affiliate)
Use of proceeds: Cement the collaboration with Yuwell and bolster Inogen's balance sheet
Jan 26, 2025

Open Financings · Read by 6ix AI from the company's releases

IPO

Priced at US$16.00 a share on Feb 13, 2014.

Price
US$16.00 a share
Shares offered
4,411,763 shares of common stock · 3,529,411 from the company and 882,352 from selling shareholders
Offering size
US$70.6 million
Underwriters' option
Up to 661,764 more shares
Underwriters
J.P. Morgan, Leerink Partners, William Blair, Stifel · In the order on the cover
Shares delivered
On or about Feb 20, 2014

Steps

StepWhen
Draft sent to the SEC in confidenceOct 16, 2013
Filed publiclyNov 27, 2013
Amended 5 timesNewest Feb 12, 2014
Shares registered with an exchangeFeb 10, 2014
Declared effective by the SECFeb 12, 2014
Final prospectus, with the priceFeb 14, 2014

Open IPO · From the cover of the final prospectus (424B4) filed Feb 14, 2014

Financials

Annual, in USD

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue348.7M335.7M315.7M377.2M358.0M308.5M361.9M358.1M249.4M202.8M
Cost of revenue194.4M181.0M189.0M223.7M181.5M170.3M190.1M179.5M128.2M105.5M
Gross profit154.3M154.7M126.7M153.5M176.5M138.2M171.9M178.6M121.2M97.3M
Research and development19.4M21.6M20.8M21.9M16.6M14.1M9.40M7.03M5.31M5.11M
Selling, general and administrative67.4M72.6M75.3M43.9M37.9M38.6M37.1M38.0M37.6M31.8M
Operating income-30.2M-42.5M-109.4M-85.2M9.24M-12.0M19.8M37.9M27.6M22.9M
Depreciation and amortization20.7M21.0M18.2M23.5M21.6M18.6M13.8M11.3M12.3M13.6M
EBITDA-9.55M-21.5M-91.2M-61.7M30.9M6.56M33.6M49.2M39.9M36.4M
Interest expense2.84M21.0M25.3M18.3M006.00K
Income before tax-23.4M-36.5M-102.3M-83.3M8.66M-5.28M24.3M40.5M29.7M22.7M
Income tax-632.0K-588.0K105.0K504.0K15.0M549.0K3.32M-11.4M8.65M2.21M
Net income-22.7M-35.9M-102.4M-83.8M-6.33M-5.83M20.9M51.8M21.0M20.5M
Earnings per share, basic-0.86-1.52-4.42-3.67-0.28-0.270.962.441.021.02
Earnings per share, diluted-0.86-1.52-4.42-3.67-0.28-0.270.942.300.960.97

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents103.7M113.8M125.5M187.0M235.5M212.0M198.0M196.6M143.0M92.9M
Short-term investments15.8M02.98M09.99M19.3M11.1M43.7M31.0M21.0M
Receivables34.1M29.6M42.2M62.7M24.5M29.7M34.3M37.0M31.4M30.8M
Inventory26.0M24.8M21.8M34.1M31.9M24.8M35.7M27.1M18.8M14.3M
Current assets224.6M185.5M207.1M304.6M329.2M305.7M292.2M314.6M228.5M161.5M
Property, plant and equipment10.1M44.4M50.3M43.3M38.9M28.2M19.4M22.3M20.1M25.2M
Goodwill10.7M9.46M10.1M32.9M33.0M33.2M33.0M2.26M2.36M0
Total assets298.6M296.2M326.2M405.0M489.5M461.9M447.3M375.9M275.1M214.0M
Accounts payable19.7M16.6M13.5M18.2M10.3M12.5M16.4M13.7M9.54M5.74M
Current liabilities63.5M76.7M72.5M65.3M61.5M56.7M50.2M46.6M33.9M22.8M
Long-term debt00
Total debt17.5M19.4M21.9M23.3M26.7M10.0M6.72M
Total liabilities106.4M122.3M121.4M107.6M119.3M112.2M102.7M65.5M48.0M32.0M
Shareholders' equity192.2M173.9M204.8M297.4M370.2M349.6M344.6M310.4M227.0M182.1M
Shares outstanding27.2M23.9M23.3M22.9M22.7M22.1M22.0M21.8M21.0M20.4M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations-11.2M5.91M-3.23M-37.5M23.6M37.0M40.6M60.0M60.5M31.0M
Capital spending-2.52M-3.36M-5.22M-3.34M-5.48M-4.38M-3.14M-8.04M-2.91M-1.72M
Free cash flow-13.7M2.55M-8.45M-40.9M18.2M32.6M37.5M51.9M57.6M29.3M
Cash from investing-26.2M-14.0M-59.3M-10.9M-14.6M-25.6M-44.1M-25.0M-24.4M-11.9M
Cash from financing24.2M265.0K960.0K380.0K15.0M2.07M4.93M18.3M14.0M7.71M
Dividends paid00
Share buybacks-546.0K-518.0K-1.35M-647.0K-350.0K-928.0K-1.21M14.0M8.03M
Change in cash-12.4M-8.08M-61.5M-48.5M23.6M13.9M1.40M53.7M50.1M26.7M

Open Financials

Filings

FilingDateTypeFiled with
8-K · Current reportNov 19, 2026Management or board changeSEC
10-Q · Quarterly reportNov 9, 2026Quarterly reportSEC
8-K · Current reportNov 5, 2026ResultsSEC
8-K · Current reportSep 30, 2026Material contractSEC
4 · Change in ownershipSep 3, 2026Insider tradeSEC
4 · Change in ownershipSep 3, 2026Insider tradeSEC
4 · Change in ownershipSep 3, 2026Insider tradeSEC
10-Q · Quarterly reportAug 7, 2026Quarterly reportSEC
8-K · Current reportAug 6, 2026ResultsSEC
S-8 · Registration statement for employee plansJul 24, 2026Offer documentSEC
Show 200 filings
FilingDateTypeFiled with
4 · Change in ownershipJul 9, 2026Insider tradeSEC
3 · Initial statement of ownershipJul 9, 2026Insider tradeSEC
4 · Change in ownershipJul 6, 2026Insider tradeSEC
144 · Notice of proposed saleJul 1, 2026Other filingsSEC
8-K · Current reportJul 1, 2026Management or board changeSEC
S-8 · Registration statement for employee plansJun 12, 2026Offer documentSEC
8-K · Current reportJun 11, 2026Management or board changeSEC
4 · Change in ownershipJun 9, 2026Insider tradeSEC
4 · Change in ownershipJun 9, 2026Insider tradeSEC
4 · Change in ownershipJun 9, 2026Insider tradeSEC
4 · Change in ownershipJun 9, 2026Insider tradeSEC
4 · Change in ownershipJun 9, 2026Insider tradeSEC
4 · Change in ownershipJun 9, 2026Insider tradeSEC
4 · Change in ownershipJun 9, 2026Insider tradeSEC
3 · Initial statement of ownershipJun 9, 2026Insider tradeSEC
4 · Change in ownershipJun 2, 2026Insider tradeSEC
144 · Notice of proposed saleMay 29, 2026Other filingsSEC
SD · Specialized disclosureMay 28, 2026ESG reportSEC
10-Q · Quarterly reportMay 8, 2026Quarterly reportSEC
8-K · Current reportMay 7, 2026ResultsSEC
S-8 · Registration statement for employee plansMay 4, 2026Offer documentSEC
ARS · Annual report to shareholdersApr 28, 2026Annual reportSEC
DEF 14A · Proxy statementApr 28, 2026Meeting noticeSEC
PRE 14A · Preliminary proxy statementApr 17, 2026Meeting noticeSEC
4 · Change in ownershipApr 8, 2026Insider tradeSEC
3 · Initial statement of ownershipApr 8, 2026Insider tradeSEC
8-K · Current reportApr 6, 2026Material contractSEC
8-K · Current reportMar 30, 2026Management or board changeSEC
SCHEDULE 13G/A · Big-stake notice, amendedMar 27, 2026Big-stake noticeSEC
4 · Change in ownershipMar 3, 2026Insider tradeSEC
4 · Change in ownershipMar 3, 2026Insider tradeSEC
4 · Change in ownershipMar 3, 2026Insider tradeSEC
4 · Change in ownershipMar 3, 2026Insider tradeSEC
4 · Change in ownershipMar 3, 2026Insider tradeSEC
4 · Change in ownershipMar 3, 2026Insider tradeSEC
S-8 · Registration statement for employee plansFeb 27, 2026Offer documentSEC
10-K · Annual reportFeb 27, 2026Annual reportSEC
8-K · Current reportFeb 24, 2026ResultsSEC
8-K · Current reportJan 12, 2026ResultsSEC
4 · Change in ownershipDec 2, 2025Insider tradeSEC
4 · Change in ownershipDec 2, 2025Insider tradeSEC
10-Q · Quarterly reportNov 6, 2025Quarterly reportSEC
8-K · Current reportNov 5, 2025ResultsSEC
4 · Change in ownershipSep 3, 2025Insider tradeSEC
4 · Change in ownershipSep 3, 2025Insider tradeSEC
4 · Change in ownershipSep 3, 2025Insider tradeSEC
10-Q · Quarterly reportAug 8, 2025Quarterly reportSEC
3 · Initial statement of ownershipAug 7, 2025Insider tradeSEC
3 · Initial statement of ownershipAug 7, 2025Insider tradeSEC
8-K · Current reportAug 7, 2025ResultsSEC
8-K · Current reportJul 29, 2025Management or board changeSEC
SCHEDULE 13G/A · Big-stake notice, amendedJul 17, 2025Big-stake noticeSEC
SD · Specialized disclosureMay 29, 2025ESG reportSEC
S-8 · Registration statement for employee plansMay 20, 2025Offer documentSEC
8-K · Current reportMay 19, 2025Management or board changeSEC
4 · Change in ownershipMay 19, 2025Insider tradeSEC
4 · Change in ownershipMay 16, 2025Insider tradeSEC
4 · Change in ownershipMay 16, 2025Insider tradeSEC
4 · Change in ownershipMay 16, 2025Insider tradeSEC
4 · Change in ownershipMay 16, 2025Insider tradeSEC
4 · Change in ownershipMay 16, 2025Insider tradeSEC
SCHEDULE 13G/A · Big-stake notice, amendedMay 15, 2025Big-stake noticeSEC
SCHEDULE 13G/A · Big-stake notice, amendedMay 15, 2025Big-stake noticeSEC
10-Q · Quarterly reportMay 8, 2025Quarterly reportSEC
8-K · Current reportMay 7, 2025ResultsSEC
ARS · Annual report to shareholdersMar 27, 2025Annual reportSEC
DEFA14A · Additional proxy materialMar 27, 2025Meeting noticeSEC
DEF 14A · Proxy statementMar 27, 2025Meeting noticeSEC
4 · Change in ownershipMar 4, 2025Insider tradeSEC
4 · Change in ownershipMar 4, 2025Insider tradeSEC
4 · Change in ownershipMar 4, 2025Insider tradeSEC
4 · Change in ownershipMar 4, 2025Insider tradeSEC
S-8 · Registration statement for employee plansFeb 28, 2025Offer documentSEC
10-K · Annual reportFeb 28, 2025Annual reportSEC
8-K · Current reportFeb 25, 2025ResultsSEC
SCHEDULE 13G · Big-stake noticeFeb 24, 2025Big-stake noticeSEC
4 · Change in ownershipFeb 4, 2025Insider tradeSEC
3 · Initial statement of ownershipFeb 4, 2025Insider tradeSEC
8-K · Current reportFeb 3, 2025Management or board changeSEC
8-K · Current reportJan 27, 2025Material contractSEC
8-K · Current reportJan 13, 2025ResultsSEC
8-K · Current reportDec 30, 2024Current reportSEC
4 · Change in ownershipDec 3, 2024Insider tradeSEC
4 · Change in ownershipDec 3, 2024Insider tradeSEC
3/A · Initial statement of ownership, amendedDec 3, 2024Insider tradeSEC
SC 13G/A · Big-stake notice, amendedNov 14, 2024Big-stake noticeSEC
10-Q · Quarterly reportNov 8, 2024Quarterly reportSEC
SC 13G/A · Big-stake notice, amendedNov 8, 2024Big-stake noticeSEC
8-K · Current reportNov 7, 2024ResultsSEC
SC 13G/A · Big-stake notice, amendedOct 22, 2024Big-stake noticeSEC
144 · Notice of proposed saleAug 9, 2024Other filingsSEC
10-Q · Quarterly reportAug 7, 2024Quarterly reportSEC
8-K · Current reportAug 6, 2024ResultsSEC
8-K · Current reportJul 31, 2024Management or board changeSEC
4 · Change in ownershipJul 24, 2024Insider tradeSEC
3 · Initial statement of ownershipJul 24, 2024Insider tradeSEC
8-K · Current reportJul 3, 2024Management or board changeSEC
S-8 · Registration statement for employee plansJun 12, 2024Offer documentSEC
4 · Change in ownershipJun 7, 2024Insider tradeSEC
4 · Change in ownershipJun 7, 2024Insider tradeSEC
4 · Change in ownershipJun 7, 2024Insider tradeSEC
4 · Change in ownershipJun 7, 2024Insider tradeSEC
8-K · Current reportJun 7, 2024Management or board changeSEC
4 · Change in ownershipJun 7, 2024Insider tradeSEC
4 · Change in ownershipJun 7, 2024Insider tradeSEC
4 · Change in ownershipJun 4, 2024Insider tradeSEC
SD · Specialized disclosureMay 31, 2024ESG reportSEC
8-K · Current reportMay 15, 2024Management or board changeSEC
144 · Notice of proposed saleMay 14, 2024Other filingsSEC
4 · Change in ownershipMay 14, 2024Insider tradeSEC
10-Q · Quarterly reportMay 8, 2024Quarterly reportSEC
8-K · Current reportMay 7, 2024ResultsSEC
4 · Change in ownershipMay 3, 2024Insider tradeSEC
4 · Change in ownershipMay 3, 2024Insider tradeSEC
SC 13G · Big-stake noticeApr 23, 2024Big-stake noticeSEC
ARS · Annual report to shareholdersApr 18, 2024Annual reportSEC
DEFA14A · Additional proxy materialApr 18, 2024Meeting noticeSEC
DEF 14A · Proxy statementApr 18, 2024Meeting noticeSEC
8-K · Current reportApr 15, 2024Management or board changeSEC
4 · Change in ownershipMar 6, 2024Insider tradeSEC
3 · Initial statement of ownershipMar 6, 2024Insider tradeSEC
4 · Change in ownershipMar 5, 2024Insider tradeSEC
4 · Change in ownershipMar 5, 2024Insider tradeSEC
4 · Change in ownershipMar 5, 2024Insider tradeSEC
S-8 · Registration statement for employee plansMar 1, 2024Offer documentSEC
S-8 · Registration statement for employee plansMar 1, 2024Offer documentSEC
10-K · Annual reportMar 1, 2024Annual reportSEC
8-K · Current reportFeb 27, 2024ResultsSEC
SC 13G/A · Big-stake notice, amendedFeb 14, 2024Big-stake noticeSEC
SC 13G/A · Big-stake notice, amendedFeb 14, 2024Big-stake noticeSEC
SC 13G/A · Big-stake notice, amendedFeb 13, 2024Big-stake noticeSEC
8-K · Current reportJan 24, 2024Management or board changeSEC
SC 13G/A · Big-stake notice, amendedJan 24, 2024Big-stake noticeSEC
3 · Initial statement of ownershipJan 11, 2024Insider tradeSEC
8-K · Current reportJan 5, 2024Management or board changeSEC
4 · Change in ownershipDec 4, 2023Insider tradeSEC
4 · Change in ownershipDec 4, 2023Insider tradeSEC
8-K · Current reportNov 27, 2023Management or board changeSEC
4 · Change in ownershipNov 13, 2023Insider tradeSEC
3 · Initial statement of ownershipNov 13, 2023Insider tradeSEC
8-K · Current reportNov 13, 2023Management or board changeSEC
10-Q · Quarterly reportNov 9, 2023Quarterly reportSEC
8-K · Current reportNov 7, 2023ResultsSEC
8-K · Current reportSep 18, 2023Acquisition or disposalSEC
3 · Initial statement of ownershipSep 15, 2023Insider tradeSEC
8-K · Current reportSep 7, 2023Management or board changeSEC
4 · Change in ownershipSep 5, 2023Insider tradeSEC
4 · Change in ownershipSep 5, 2023Insider tradeSEC
4 · Change in ownershipSep 5, 2023Insider tradeSEC
8-K · Current reportAug 11, 2023Management or board changeSEC
10-Q · Quarterly reportAug 8, 2023Quarterly reportSEC
8-K · Current reportAug 7, 2023ResultsSEC
8-K · Current reportJul 31, 2023Management or board changeSEC
SC 13G · Big-stake noticeJul 24, 2023Big-stake noticeSEC
8-K · Current reportJul 18, 2023Material contractSEC
8-K · Current reportJul 13, 2023ResultsSEC
SC 13G/A · Big-stake notice, amendedJul 10, 2023Big-stake noticeSEC
SC 13G/A · Big-stake notice, amendedJul 7, 2023Big-stake noticeSEC
S-8 · Registration statement for employee plansJun 6, 2023Offer documentSEC
8-K · Current reportJun 5, 2023Management or board changeSEC
4 · Change in ownershipJun 5, 2023Insider tradeSEC
4 · Change in ownershipJun 5, 2023Insider tradeSEC
4 · Change in ownershipJun 5, 2023Insider tradeSEC
4 · Change in ownershipJun 5, 2023Insider tradeSEC
4 · Change in ownershipJun 2, 2023Insider tradeSEC
4 · Change in ownershipJun 2, 2023Insider tradeSEC
4 · Change in ownershipJun 2, 2023Insider tradeSEC
4 · Change in ownershipJun 2, 2023Insider tradeSEC
4 · Change in ownershipJun 2, 2023Insider tradeSEC
4 · Change in ownershipJun 2, 2023Insider tradeSEC
SD · Specialized disclosureMay 30, 2023ESG reportSEC
DEFA14A · Additional proxy materialMay 11, 2023Meeting noticeSEC
10-Q · Quarterly reportMay 5, 2023Quarterly reportSEC
8-K · Current reportMay 4, 2023ResultsSEC
DEFA14A · Additional proxy materialApr 28, 2023Meeting noticeSEC
ARS · Annual report to shareholdersApr 18, 2023Annual reportSEC
DEFA14A · Additional proxy materialApr 18, 2023Meeting noticeSEC
DEF 14A · Proxy statementApr 18, 2023Meeting noticeSEC
4 · Change in ownershipApr 4, 2023Insider tradeSEC
3 · Initial statement of ownershipApr 4, 2023Insider tradeSEC
8-K · Current reportMar 22, 2023Management or board changeSEC
4 · Change in ownershipMar 2, 2023Insider tradeSEC
4 · Change in ownershipMar 2, 2023Insider tradeSEC
4 · Change in ownershipMar 2, 2023Insider tradeSEC
4 · Change in ownershipMar 2, 2023Insider tradeSEC
4 · Change in ownershipMar 2, 2023Insider tradeSEC
4 · Change in ownershipMar 2, 2023Insider tradeSEC
S-8 · Registration statement for employee plansFeb 24, 2023Offer documentSEC
10-K · Annual reportFeb 24, 2023Annual reportSEC
8-K · Current reportFeb 23, 2023ResultsSEC

This page holds 200 of 1,000 filings. Open Filings

Open Filings · All of its filings on SEC EDGAR

Cap table

Built by 6ix from Inogen, Inc’s releases · as of Jan 26, 2025

Common shares
26,538,337
Fully diluted
26,538,337

Fully diluted

LineShares
Common shares26,538,337

Share count over time

CountShares
Nov 22, 202626,538,337

Open Cap table

Shareholders

Institutions

HolderSharesOf the companyValueChange vs Jun 30Filed
BlackRock1.74M6.7%US$9.2M−4,204Nov 13, 2026
Vanguard1.48M5.7%US$7.82M+20,287Nov 16, 2026
Armistice Capital, LLC1.24M4.8%US$6.51M+140KNov 16, 2026
Acadian Asset Management LLC1.1M4.2%US$5.78MNo changeNov 9, 2026
DAFNA Capital Management LLC845K3.3%US$4.45MNo changeNov 16, 2026
Arrowstreet Capital, Limited Partnership778K3.0%US$4.1M+34,831Nov 13, 2026
Morgan Stanley692K2.7%US$3.64M+45,315Nov 13, 2026
JPMorgan680K2.6%US$3.65M+200KNov 12, 2026
AQR Capital Management LLC655K2.5%US$3.45M−283KNov 16, 2026
State Street592K2.3%US$3.12M−359Nov 12, 2026
Show 50 holders
HolderSharesOf the companyValueChange vs Jun 30Filed
Federated Hermes, Inc.566K2.2%US$2.98M+31,099Nov 12, 2026
Goldman Sachs558K2.1%US$2.94M+123KNov 16, 2026
Geode Capital535K2.1%US$2.82M−107KNov 6, 2026
Renaissance Technologies479K1.8%US$2.52M+2,300Nov 12, 2026
Dimensional456K1.8%US$2.4M−32,759Nov 4, 2026
CSM Advisors, LLC380K1.5%US$2M−33,925Nov 13, 2026
Citadel323K1.2%US$1.7MNewNov 16, 2026
Jacobs Levy Equity Management, Inc322K1.2%US$1.7M−66,625Nov 16, 2026
Peapod Lane Capital LLC268K1.0%US$1.41M+5,369Oct 22, 2026
Readystate Asset Management LP246K0.95%US$1.3M−20,224Nov 16, 2026
Point72 Asset Management, L.P.227K0.87%US$1.2M+55,994Nov 16, 2026
Moore Capital Management, LP225K0.87%US$1.19M−63,895Nov 16, 2026
Steward Partners Investment Advisory, LLC205K0.79%US$1.08M+3,650Nov 13, 2026
Quantinno Capital Management LP203K0.78%US$1.07M+70,155Nov 13, 2026
Bridgeway Capital Management, LLC194K0.75%US$1.02M−622Nov 16, 2026
UBS194K0.75%US$1.02M−108KNov 16, 2026
Northern Trust192K0.74%US$1.01M−4,777Nov 16, 2026
Prudential Financial Inc167K0.64%US$881K−162KNov 16, 2026
Nuveen164K0.63%US$862K−21,999Nov 10, 2026
Marshall Wace, LLP161K0.62%US$847KNewNov 13, 2026
Monaco Asset Management SAM136K0.52%US$715K−25,000Nov 9, 2026
Russell Investments Group, Ltd.133K0.51%US$702K+101KNov 6, 2026
BNY118K0.45%US$622K−401Nov 5, 2026
D. E. Shaw & Co., Inc.118K0.45%US$621K+80,728Nov 16, 2026
Credit Agricole S A112K0.43%US$590KNo changeNov 13, 2026
Ameriprise109K0.42%US$574K−874KNov 16, 2026
Tocqueville Asset Management L.P.93,3500.36%US$492KNo changeNov 13, 2026
Schwab81,3690.31%US$429K+7,204Nov 16, 2026
Connor, Clark & Lunn Investment Management Ltd.71,0160.27%US$374K+29,431Nov 10, 2026
Invesco66,7280.26%US$352K+5,340Nov 12, 2026
American Century60,3560.23%US$318K−479Nov 20, 2026
Mackenzie58,6970.23%US$309K−152KNov 2, 2026
AllianceBernstein57,9200.22%US$305KNo changeNov 16, 2026
Panagora Asset Management Inc53,7140.21%US$283K+1,291Nov 12, 2026
BNP Paribas51,6100.20%US$272K−12,834Nov 12, 2026
Barclays48,3340.19%US$255K+5,727Nov 6, 2026
Campbell & CO Investment Adviser LLC47,8930.18%US$252K−15,923Nov 13, 2026
XTX Topco Ltd45,6960.18%US$241K+2,320Nov 16, 2026
Assenagon Asset Management S.A.44,1850.17%US$233K−130KOct 15, 2026
Mercer Global Advisors Inc42,5710.16%US$224K+11,634Nov 16, 2026

This page holds 50 of 133 holders. Open Shareholders

Funds

HolderSharesOf the companyValueChangeAs of
Vanguard Total Stock Market Index Fund740K2.8%US$4.77MNo changeJun 30, 2026
Columbia Small Cap Value Discovery Fund644K2.5%US$4.16M+39,100Jul 31, 2026
iShares Russell 2000 ETF644K2.5%US$4.15M+61,514Jun 30, 2026
Federated Hermes MDT Small Cap Core Fund371K1.4%US$2.4MNo changeJul 31, 2026
Vanguard Extended Market Index Fund271K1.0%US$1.75M+6,275Jun 30, 2026
Fidelity Small Cap Index Fund267K1.0%US$1.72M+32,997Jul 31, 2026
iShares Russell 2000 Value ETF219K0.84%US$1.41M+18,291Jun 30, 2026
Ultra-Small Company Fund156K0.60%US$1M+30,000Jun 30, 2026
College Retirement Equities Fund - Total Global Stock Account133K0.51%US$859K−178KJun 30, 2026
Fidelity Extended Market Index Fund131K0.50%US$847K+4,588May 31, 2026
Show 50 holders
HolderSharesOf the companyValueChangeAs of
Vanguard Russell 2000 Index Fund123K0.47%US$797K+5,424May 31, 2026
U.S. Small Cap Portfolio121K0.46%US$778KNo changeJul 31, 2026
Columbia Variable Portfolio - Small Cap Value Discovery Fund117K0.45%US$752K−4,100Jun 30, 2026
JPMorgan U.S. Small Company Fund94,6350.36%US$610K−6,835Jun 30, 2026
Vanguard Strategic Small-Cap Equity Fund88,5720.34%US$571KNo changeJun 30, 2026
U.S. Micro Cap Portfolio84,5710.33%US$545KNo changeJul 31, 2026
iShares Micro-Cap ETF82,8730.32%US$535K+23,614Jun 30, 2026
Goldman Sachs Small Cap Value Insights Fund82,5290.32%US$532K−76,702Jul 31, 2026
JPMorgan Small Cap Value Fund81,6930.31%US$527KNewJun 30, 2026
AST PGIM Aggressive Multi-Asset Portfolio73,6000.28%US$475K−22,500Jun 30, 2026
Federated Hermes MDT Small Cap Core ETF68,2190.26%US$443K+28,783May 31, 2026
Multi-Manager Small Cap Equity Strategies Fund66,8080.26%US$434K+20,200May 31, 2026
Dimensional U.S. Small Cap ETF58,9940.23%US$381K−31,534Jul 31, 2026
Schwab Small-Cap Index Fund57,5620.22%US$371K+6,158Jul 31, 2026
Jacob Discovery Fund55,0000.21%US$357K+13,000May 31, 2026
U.S. Small Cap Equity Fund49,1120.19%US$317K+42,877Jul 31, 2026
Avantis U.S. Small Cap Equity ETF48,6440.19%US$316KNo changeMay 31, 2026
Fidelity Total Market Index Fund47,8190.18%US$310KNo changeMay 31, 2026
NVIT Multi-Manager Small Company Fund47,2210.18%US$305KNo changeJun 30, 2026
Dimensional U.S. Core Equity 2 ETF41,5090.16%US$268KNo changeJul 31, 2026
Master Small Cap Index Series41,2100.16%US$266KNo changeJun 30, 2026
NVIT Small Cap Value Fund39,7300.15%US$256KNo changeJun 30, 2026
Small Cap Equity Fund38,4190.15%US$248K+2,441Jun 30, 2026
Fidelity Series Total Market Index Fund37,5440.14%US$244KNo changeMay 31, 2026
Ultra-Small Company Market Fund36,7000.14%US$237KNo changeJun 30, 2026
Federated Hermes MDT Small Cap Value Fund f/k/a Federated Hermes Clover Small Value Fund36,1140.14%US$233KNo changeJun 30, 2026
Fidelity Small Cap Value Index Fund34,3520.13%US$222K+4,994Jun 30, 2026
Nuveen Small Cap Blend Index Fund32,0570.12%US$207KNo changeJul 31, 2026
Invesco RAFI US 1500 Small-Mid ETF32,0450.12%US$207K−3,288Jul 31, 2026
U.S. Core Equity 1 Portfolio28,7020.11%US$185KNewJul 31, 2026
EQ/2000 Managed Volatility Portfolio28,3120.11%US$183KNo changeJun 30, 2026
Goldman Sachs Absolute Return Tracker Fund27,3330.11%US$176K+11,846Jun 30, 2026
Cultivar ETF26,7220.10%US$172K+1,656Jul 31, 2026
EQ/Small Company Index Portfolio26,6400.10%US$172K+3,400Jun 30, 2026
EQ/AB Small Cap Growth Portfolio23,7200.09%US$153K+3,400Jun 30, 2026
LVIP JPMorgan Small Cap Core Fund21,1180.08%US$136K−1,194Jun 30, 2026
JPMorgan Small Cap Value Portfolio20,5680.08%US$133KNewJun 30, 2026
T. Rowe Price Extended Equity Market Index Fund20,0000.08%US$129KNo changeJun 30, 2026
Vanguard Russell 2000 Value Index Fund18,1330.07%US$118K+821May 31, 2026
Schwab Total Stock Market Index Fund16,5550.06%US$107KNo changeJul 31, 2026

This page holds 50 of 151 holders. Open Shareholders

Insider trades

InsiderTradeSharesPriceValueDate
Yi Boyer Jennifer M
Officer: EVP Entrprs Enblmnt, Ch HR Off
Sale10,938USD 6.60US$72,191Jul 1, 2026
Yi Boyer Jennifer M
Officer: EVP Entrprs Enblmnt, Ch HR Off
Sale10,770USD 6.53US$70,328May 29, 2026

Big stakes

HolderStakeSharesDate
Yuwell (Hong Kong) Holdings Limited9.90%2.63MFeb 21, 2025
BlackRock, Inc.6.20%1.66MJun 30, 2025

Open Shareholders

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
William J. Link
Other companies: RxSight, Inc. (Director · Since at least Jul 29, 2021); Tarsus Pharmaceuticals, Inc. (Director · Since at least Oct 15, 2020); LENSAR, Inc. (Director · Since at least Sep 17, 2020); Oyster Point Pharma Inc (Director · Oct 30, 2019 – Jan 5, 2022 · Past); Glaukos Corporation (Director · Jun 24, 2015 – Jun 3, 2021 · Past); Vivani Medical, Inc. (Director · Nov 18, 2014 – Jun 4, 2019 · Past); Flexion Therapeutics Inc (Director · Sep 10, 2014 – Sep 10, 2014 · Past); Edwards Lifesciences Corporation (Director · May 15, 2013 – May 8, 2020 · Past)
Director · Feb 12, 2014 – Feb 20, 2014 · Past
Elizabeth Mora
Other companies: Allbirds, Inc. (Director · Since at least Oct 1, 2026); Limoneira Co (Director · Since at least Nov 1, 2021); MKS Inc. (Director · Since at least May 7, 2012); Nuburu, Inc. (Director · Jan 31, 2023 – Aug 31, 2023 · Past); Everest Consolidator Acquisition Corporation (Director · Nov 23, 2021 – Nov 23, 2021 · Past); GCP Applied Technologies Inc (Director · Feb 3, 2016 – Jun 1, 2020 · Past)
Chairperson of the Board · Since at least May 24, 2021
Thomas A. West
Other companies: CeriBell, Inc. (Director · Since at least Jul 28, 2026); SI-BONE, Inc. (Director · Since at least Jun 25, 2024); Orthofix Medical Inc. (Director · Dec 13, 2021 – Dec 31, 2022 · Past); Intersect ENT Inc (President and CEO, Director · Jul 22, 2019 – May 13, 2022 · Past); Hologic Inc (Div President & GM, Diagnostic · Oct 3, 2014 – Dec 1, 2018 · Past)
Director · Apr 1, 2023 – Jun 5, 2024 · Past
Mary Kay Ladone
Other companies: Kestra Medical Technologies, Ltd. (Director · Since at least Mar 6, 2025); Novanta Inc. (Director · Since at least Jul 11, 2024); Bioventus Inc. (Director · Since at least Jul 15, 2021); Hill-Rom Holdings Inc (SVP, Corp. Dev., Strat. & IR · Dec 3, 2018 – Dec 13, 2021 · Past)
Director · Since at least Mar 22, 2022
R. Scott Greer
Other companies: Nektar Therapeutics (Managing Director, Numenor Ventures, LLC · Since at least Sep 15, 2015); Microbot Medical Inc. (Director · Jan 1, 2016 – Jan 1, 2016 · Past); Aravive Inc (Director · Jun 29, 2015 – Dec 20, 2017 · Past); Sientra Inc (Director · Jun 26, 2015 – Jun 5, 2018 · Past)
Director · Aug 3, 2015 – May 10, 2021 · Past
Glenn Boehnlein
Other companies: DexCom, Inc. (Director · Since at least Sep 10, 2026); Agilent Technologies, Inc. (Director · Since at least Sep 4, 2026); Stryker Corporation (VP, Chief Financial Officer · Apr 1, 2016 – Mar 21, 2025 · Past)
Director · Since at least Mar 22, 2022
Heath Lukatch
Other companies: Vaxcyte, Inc. (Director · Since at least Jun 11, 2020); Satsuma Pharmaceuticals Inc (Director · Sep 12, 2019 – Jun 8, 2023 · Past); Flexion Therapeutics Inc (Director · Feb 11, 2014 – Nov 19, 2021 · Past)
Director · Feb 12, 2014 – May 10, 2021 · Past
Alison Bauerlein
Other companies: Sight Sciences, Inc. (Chief Operating Officer · Since at least Apr 3, 2023); Pear Therapeutics Inc (Director · Dec 3, 2021 – Feb 15, 2023 · Past)
EVP, Finance, & CFO · Mar 31, 2016 – Dec 1, 2021 · Past
Michael J Bourque
Other companies: Chase Corporation (Treasurer & CFO · Feb 2, 2021 – Nov 15, 2023 · Past); Analogic Corporation (See Remarks · Apr 24, 2015 – Jun 22, 2018 · Past)
EVP, CFO & Treasurer · Since at least Mar 4, 2024
Raymond O. Huggenberger
Other companies: Tactile Systems Technology, Inc. (Director · Since at least Sep 20, 2017); IntriCon Corporation (Director · Apr 26, 2019 – May 24, 2022 · Past)
Director · Feb 12, 2014 – Sep 15, 2021 · Past
All 46 people
PersonSeat
Andy Reding
Other companies: Axe Compute Inc. (Director · Oct 19, 2009 – Jun 30, 2020 · Past)
Chief Operating Officer · Since at least Jul 1, 2026
Brenton Taylor
Other companies: Sight Sciences, Inc. (EVP, Operations & R&D · Since at least Nov 4, 2024)
EVP, Engineering · Feb 12, 2014 – Sep 28, 2021 · Past
Gregoire Ramade
Other companies: Vapotherm Inc (SVP & Chief Commercial Officer · Jan 1, 2020 – Jan 2, 2023 · Past)
Chief Commercial Officer · Since at least Jan 2, 2024
Heather D. Rider
Other companies: IntriCon Corporation (Director · Mar 20, 2020 – May 24, 2022 · Past)
Director · Since at least Aug 6, 2014
Jason Richardson
Other companies: Hill-Rom Holdings Inc (Corporate Controller · Mar 14, 2016 – Nov 18, 2017 · Past)
Chief Financial Officer · Since at least Mar 30, 2026
Kevin King
Other companies: iRhythm Holdings, Inc. (Director · Oct 19, 2016 – Mar 4, 2022 · Past)
Director · Since at least Mar 22, 2022
Loren L McFarland
Other companies: Mentor Corp (CFO · Jun 13, 2006 – Oct 5, 2007 · Past)
Director · Feb 12, 2014 – Jan 11, 2022 · Past
Michael K Sergesketter
Other companies: Kimball Electronics, Inc. (Vice President · Oct 7, 2014 – Aug 24, 2020 · Past)
EVP, CFO, and Treasurer · Dec 13, 2021 – Sep 11, 2023 · Past
Nabil Shabshab
Other companies: Becton, Dickinson and Company (Executive Vice President · Jan 29, 2013 – May 11, 2018 · Past)
CEO and President, Director · Feb 8, 2021 – Sep 1, 2023 · Past
Ray Benjamin M Anderson
Other companies: Chromcraft Revington Inc (Chairman and CEO, Director · Sep 26, 2007 – Sep 26, 2007 · Past)
Director · Feb 12, 2014 – Mar 3, 2022 · Past
Timothy Petersen
Other companies: SI-BONE, Inc. (Director · Oct 16, 2018 – Oct 19, 2018 · Past)
Director · Feb 12, 2014 – May 29, 2015 · Past
Vafa Jamali
Other companies: ZimVie Inc (See remarks below., Director · Since at least Feb 7, 2022)
Director · Since at least Apr 6, 2026
Arron RettererEVP, Sales · Aug 17, 2020 – Mar 1, 2021 · Past
Bart Ben SanfordEVP, Operations · Sep 17, 2018 – Mar 1, 2023 · Past
Boyer Jennifer M YiEVP Entrprs Enblmnt, Ch HR Off · Since at least Jul 28, 2025
Byron MyersEVP, Marketing · Feb 12, 2014 – Mar 15, 2021 · Past
Charles E LarsenDirector · Feb 12, 2014 – Apr 1, 2014 · Past
Dominic HultonChief Marketing Officer · Since at least Mar 30, 2026
George J ParrChief Commercial Officer · Apr 12, 2021 – Jun 1, 2023 · Past
Jason SomerEVP, Gen. Counsel & Secretary · Jul 12, 2021 – Jun 1, 2024 · Past
Jennifer Yi BoyerExecutive Vice President, Enterprise Enablement and Chief Human Resources Officer · Since at least Nov 5, 2026
Kevin P SmithEVP, Bus Dev, GC & Sec · Since at least Jul 22, 2024
Kevin R.M. SmithGeneral Counsel and Executive Vice President, Business Development · Since at least Nov 10, 2023
Krishna JhaveriChief Medical Officer · Since at least Nov 5, 2026
Kristen MirandaDirector · Mar 1, 2021 – Jun 8, 2022 · Past
Kristin A CaltriderEVP, CFO and Treasurer · Mar 21, 2022 – Feb 28, 2023 · Past
Mary E WrightVP, Chief Accounting Officer · Since at least Jul 28, 2025
Matt ScribnerEVP, Operations · Feb 12, 2014 – Sep 1, 2018 · Past
Mira Kirti SahneyDirector · Since at least Jan 31, 2025
Naga RameswamyChief Technology Officer · Since at least Sep 25, 2025
Paul AndreassiExecutive Vice President, Chief Quality and Regulatory Affairs Officer · Since at least Nov 5, 2026
Philip CorrinSenior Vice President, Operations and Supply Chain · Since at least Nov 5, 2026
Scott BeardsleyDirector · Jan 1, 2017 – Jan 1, 2017 · Past
Scott WilkinsonPresident and CEO, Director · Feb 12, 2014 – Dec 1, 2020 · Past
Stanislav GlezerEVP, R&D & Chief Med. Officer · Jun 21, 2021 – May 1, 2024 · Past
Stephen E CooperDirector · Feb 12, 2014 – Feb 20, 2014 · Past

Open People

Log in to ask 6ix AI your own questions about Inogen, Inc.